About 35Pharma
35Pharma is a company based in Montreal (Canada) founded in 2021 was acquired by GSK in February 2026. It operates as a B2B. 35Pharma offers products and services including HS135, HS235, and Ligand Traps. 35Pharma operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter Montreal, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name 35Pharma Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of 35Pharma
35Pharma offers a comprehensive portfolio of products and services, including HS135, HS235, and Ligand Traps.
Therapeutic for treating pulmonary hypertension and related diseases
Therapeutic for cardiometabolic disease and obesity management
Protein-based traps neutralizing pathological factors in diseases
People of 35Pharma
Unlock access to complete
Funding Insights of 35Pharma
Detailed funding history for 35Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in 35Pharma
35Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include GSK.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
Locked | Locked | Locked |
Investor details for 35Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 35Pharma
Investment portfolio details for 35Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - 35Pharma
Detailed financials for 35Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
35Pharma Comparisons
Peer comparison for 35Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 35Pharma
35Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| Locked | Locked | Locked |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| Locked | Locked | Locked |
Drug research, development, testing, and consulting services are provided.
|
|
| Locked | Locked | Locked |
Provides contract research, development, and manufacturing services for biologic drugs.
|
Detailed competitors of 35Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 35Pharma
Complete news archive for 35Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 35Pharma
35Pharma was founded in 2021.
35Pharma is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
35Pharma is a biopharmaceutical company that designs and develops biologics targeting the TGF-beta superfamily for diseases like pulmonary hypertension and obesity. It combines protein engineering expertise with rigorous manufacturing processes to create potent ligand traps. Based in Montreal, Canada, the company advances therapies through clinical trials and partnerships, aiming to improve patient outcomes with a focus on urgent medical needs.
35Pharma offers HS135, HS235, and Ligand Traps.
35Pharma has 1 investor. Key investors include GSK.